This research intends to examine the clinical characteristics and genetic diversity of a child experiencing epilepsy with myoclonic-atonic seizures (EMAS) attributed to a variant in the SLC6A1 gene. The gene discussed is SLC6A1; the disease is Generalized myoclonic-atonic seizure.